Global Data

In an increasingly fast-paced, complex and uncertain world, it has never been more difficult for organizations and decision-makers to predict and navigate the future. That's why Global Data's mission is to help our customers decode the future and benefit from faster, better-informed decisions.

As a leading information services company, thousands of customers rely on Global Data for reliable, timely and actionable intelligence.

Its solutions are designed to provide a day-to-day advantage for professionals in corporations, financial institutions, professional services and government agencies.

Since 2016, Global Data's Healthcare division has been supplying and analyzing data for heavyweights in the pharmaceutical and medical industries worldwide. It is the group's largest branch.

With the majority of its 2,000 customers highly satisfied with its services, Global Data's Healthcare division generates 80% recurring revenues. It works with some of Europe's biggest pharmaceutical companies, including British giant GlaxoSmithKline (GSK).

The company's development strategy relies mainly on a solid command of M&A, which translates into frequent acquisitions. It is clear that this technique is working, with sales up 10% between 2022 and 2023, and Global Data steadily increasing its market share since 2020.